PAREXEL Simplifies Drug Development Journey From Science To New Treatments
[PR Newswire] – BOSTON, Feb. 12, 2014 /PRNewswire/ — As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation (PRXL), a leading global biopharmaceuti moreView todays social media effects on PRXLView the latest stocks trending across Twitter. Click to view dashboardSee who PAREXEL is hiring next, click here to […]